Role of hydroxyapatite nanoparticle size in bone cell proliferation

TLDR

The study synthesized hydroxyapatite nanoparticles of 20 ± 5, 40 ± 10, and 80 ± 12 nm and examined their impact on proliferation of bone marrow mesenchymal stem cells and osteosarcoma cells. The experiments revealed that 20‑nm hydroxyapatite nanoparticles enhanced MSC proliferation and cytophilicity while inhibiting osteosarcoma growth, underscoring particle size as a critical factor for biomineralization activity.

Abstract

Hydroxyapatite (HAP) nanoparticles, typically 20 ± 5, 40 ± 10 and 80 ± 12 nm in diameter, were prepared and their effects on the proliferation of two bone-related cells, bone marrow mesenchymal stem cells (MSCs) and osteosarcoma cells (U2OS) were studied. The cell culture experiments showed improved cytophilicity of the nanophase mineral as compared with conventional HAP. Greater cell viability and proliferation of MSCs were measured on the nano HAP, remarkably for 20 nm sized particles. Interestingly, the growth of osteosarcoma cells was inhibited by the nano HAP and 20 nm sized particles were the best retardant. It is suggested that the HAP nanoparticles can exhibit favorable cell proliferation to optimize biological functionality, in which the particle size is believed to play a key role. These in vitro findings are of great significance for the understanding of cytophilicity and biological activity of nanoparticles during biomineralization.